Fig. 1: In vitro inhibition of JUNV infection by anti-hTfR1 antibodies. | Nature Communications

Fig. 1: In vitro inhibition of JUNV infection by anti-hTfR1 antibodies.

From: Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections

Fig. 1

Virus titers determined by endpoint titration of culture supernatant collected 4 days after infection from A549 cell cultures infected with JUNV-C1 or JUNV Romero and treated with increasing concentrations of ch128.1/IgG1, ch128.1/IgG1 mutant, or control IgG1/κ antibodies. Means ± standard deviations (SDs) of experimental replicates (n = 3) are shown. Fifty percent cell culture infectious dose (CCID50). Source data are included in the Source Data file.

Back to article page